chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At time of vaccine patient had pox formation on bridge of nose fever and flu like illness with dizzy feeling. Approx. 2 months later she developed tinnitus and vertigo which worsened to requiring hospitalization. She had a VNG which showed unilateral weakness on the right consistent with a peripheral nerve lesion. I am not sure related to ZOSTAVAX but wanted to make sure.
Flu like ache; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like ache) and PAIN IN EXTREMITY (Sore arm) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like ache) and PAIN IN EXTREMITY (Sore arm). On 05-Feb-2021, INFLUENZA LIKE ILLNESS (Flu like ache) and PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.    This case was linked to MOD-2021-022642, MOD-2021-021496, MOD-2021-021088 (Patient Link).
Mom felt it somehow affected haring and not brought in to evaluate. Subsequent hearing and neurologic end was normal.
pt recvd flu vax & devel generalized itching; treated w/DPH;
This spontaneous report was received from a physician and from a support services director via company representatives and refers to a patient of an unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 23-SEP-2015, the patient was vaccinated with a dose of an improperly stored GARDASIL 9 (strength: 0.5 ml) lot # L014198 and expiration date: 05-SEP-2017 (dose, anatomical location and route of administration were not reported). No adverse effects were reported. The dose of the vaccine was exposed to a temperature excursion (date unspecified): lasting for 48 hours, with the lowest recorded temperature of 33 degrees Fahrenheit (0.55 degrees Celsius). The vaccine was stored in a refrigerator. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Numbness in the left side of the body and he cannot feel anything in his left side; Left foot feels cold; Back pain; This spontaneous case was reported by a nurse and describes the occurrence of HYPOAESTHESIA (Numbness in the left side of the body and he cannot feel anything in his left side), PERIPHERAL COLDNESS (Left foot feels cold) and BACK PAIN (Back pain) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 046B21A) for COVID-19 immunisation.     No medication history was provided.  Concurrent medical conditions included Allergic reaction to antibiotics (Keflex).   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced HYPOAESTHESIA (Numbness in the left side of the body and he cannot feel anything in his left side), PERIPHERAL COLDNESS (Left foot feels cold) and BACK PAIN (Back pain). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) ongoing since an unknown date for Vitamin supplementation, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (Numbness in the left side of the body and he cannot feel anything in his left side), PERIPHERAL COLDNESS (Left foot feels cold) and BACK PAIN (Back pain) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication use was unknown   This case was linked to MOD-2021-155226 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Medication allergies have been added. HCP contact information (fax no.) has been added. On 24-Jun-2021: Non-Significant Follow-up added
Patient reported arm very sore, red, painful at injection site and moved down past elbow. Advised to take acetaminophen and antihistamine.
ER visit 1/25/21 patient walked into a prompt care and collapsed, witnessed and pulseless CPR with ROSC after 6-7mins, no shock no meds.  Awake and speaking upon arrival to ER.  2 plus pitting edema ble ER diagnosis Anasarca, cardiac arrest, hypotension, elevated troponin I levels, Acute kidney injury and syncope.  ER notes reveal a syncopal episode in the shower prior to collapse at prompt care.  Central line placed and plan to ship to another facility, patient continued to decline despite dopamine and dobutamine expired in ER prior to transfer.
SEVERE ARM PAIN JAW PAIN BODY ACHES CHILLS  NO FEVER REALLY BAD NAUSEA
The patient developed constant high pitched tinnitus in both ears between 12 and 24 hrs after receiving his 2nd covid19 vaccine (moderna).  This has persisted x 2 weeks thus far w/o improvement.
Extreme arm ache, red raised area 2 inches diameter, stomach upset, headache, night sweats
Abdominal pain; Nausea; Diarrhea; Stomach cramps; Muscle spasms; Chills; Sweats; This is a spontaneous report from a contactable pharmacist, the patient. A 75-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 12Apr2021 at 10:00 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. Medical history included anemia iron deficiency, hypertension (HTN), hypothyroidism and post-menopausal (Post menopause). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. On 15Apr2021 at 13:00, the patient experienced abdominal pain, nausea, diarrhea, stomach cramps, muscle spasms, chills and sweats. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events abdominal pain, nausea, diarrhea, stomach cramps, muscle spasms, chills and sweats were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Immediate high pain (9/10) at injection site, difficulty raising right arm, pain in axillary and shoulder. I took a photograph of the injection site just after  it.  After 11 days with continuing difficulty to lift right arm, discomfort and achy feeling in right shoulder, weakness right arm, difficulty sleeping due to not finding a comfortable position for right shoulder., I contacted provider clinic via portal and by telephone. I asked to be referred to Ortho for assessment which was done. On  Oct 19,I went for appt 3 pm to see Orthopedic Dr. Xrays were taken at that time showing position of shoulder in relation to puncture site of injection. It was determined that  as per the xrays, the injection had entered in the shoulder capsule area . Dr prescribed MethylPREDNISolone 4 mg, 8 day treatment, to treat the right shoulder inflammation.
I woke up a day later from the vaccine and I had a rash and hives around my right side of my body. They almost looked like pimples and they blistered and hurt really bad and itched but the more I scratched the more they hurt. I took Benadryl and cortizone at home but it did nothing and I had to see a doctor to get a steroid shot to make them go away. Some of them were really large, almost the size of apples and others where smaller like the tip of the pinky finger in size. Lasted for about a week, mostly due because that's how long it took me to go see a doctor and get it treated.
2 weeks after completing second COVID vaccine, previously regular menses became extremely irregular, with bleeding every 2 weeks instead of every 4 weeks
14days p/vax pt exp classic chickenpox w/25-30 lesions. pt seen by MD & was rpt to have low grade fever, runny nose, cold sx, & upper respiratory infect. treated w/amoxil & benadryl
reaction to the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (reaction to the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION COMPLICATION (reaction to the Moderna vaccine). At the time of the report, VACCINATION COMPLICATION (reaction to the Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.; Sender's Comments: Very limited information regarding this "vaccination adverse reaction" event has been provided at this time.  Further information has been requested.
A report has been received from a Health Professional concerning a 2 year old, male subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. The reporter stated patient received FLUMIST on 28-sep-2013 and moved while the second half was being dispensed. T went all over his fence instead of his nose and was squirming. The outcome of the event of squirming, partial dose of FLUMIST and FLUMIST sprayed in face is unknown. The report ws considered to be non-serious.
71y.o. male with PMHx of Alcohol abuse, started drinking because his family is in Country and he has his son that lives nearby.  Patient went to elsewhere and was transferred here to facility via Ambulance.  Patient drinks about 1 fifth a day of alcohol.  Patient stated that he stopped drinking for awhile and restarted again.  Patient states his doctor has put him on librium and ativan in he past bu that seems not to be helping his situation. Discussed discharge plans with his son
A little tender, 2 or 3 square inch area; Hardness; There is swollen; Her arm at the injection site is red; She was exposed to the sun straight for about 35 minutes; There were little bumps; At the arm in the injection site it began to itch; A sore arm very local to the area of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY EXPOSURE TO ULTRAVIOLET LIGHT (She was exposed to the sun straight for about 35 minutes), TENDERNESS (A little tender, 2 or 3 square inch area), INDURATION (Hardness), SWELLING (There is swollen) and VACCINATION SITE PRURITUS (At the arm in the injection site it began to itch) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (A sore arm very local to the area of the injection site). On 22-Mar-2021, the patient experienced HEAVY EXPOSURE TO ULTRAVIOLET LIGHT (She was exposed to the sun straight for about 35 minutes), VACCINATION SITE PRURITUS (At the arm in the injection site it began to itch) and INJECTION SITE SWELLING (There were little bumps). On 23-Mar-2021, the patient experienced TENDERNESS (A little tender, 2 or 3 square inch area), INDURATION (Hardness), SWELLING (There is swollen) and VACCINATION SITE ERYTHEMA (Her arm at the injection site is red). On 19-Mar-2021, VACCINATION SITE PAIN (A sore arm very local to the area of the injection site) had resolved. On 22-Mar-2021, HEAVY EXPOSURE TO ULTRAVIOLET LIGHT (She was exposed to the sun straight for about 35 minutes), VACCINATION SITE PRURITUS (At the arm in the injection site it began to itch) and INJECTION SITE SWELLING (There were little bumps) had resolved. At the time of the report, TENDERNESS (A little tender, 2 or 3 square inch area), INDURATION (Hardness), SWELLING (There is swollen) and VACCINATION SITE ERYTHEMA (Her arm at the injection site is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included anti itch cream (1% cortisone). Caladryl  (Pramoxine-calamine).   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow-up received contains no new information.
At 0947, patient reported headache rated 5/10 on the pain scale and chest pain radiating to left shoulder (patient received vaccine on left arm). EMT assessed patient vitals: blood pressure 158/90 mmHg, heart rate regular 69 beats/minute, and SpO2 96%. Patient denied difficulty breathing, difficulty swallowing, itchiness, hives and rashes. Patient reported history of atrial fibrillation, pulmonary embolism, and surgeries on elbows, ankles and esophagus. Patient denied taking current medications. Patient offered 911. Patient declined 911. Patient given water and advised to wait for further observation. Patient reassessed at 1005. Patient vitals were blood pressure 149/90 mmHg, heart rate 67 beats/minute, and SpO2 97%. Patient reported headache decreased to 2/10 on the pain scale. Patient reassessed at 1015. Patient vitals were blood pressure 144/88 mmHg, heart rate 65 beats/minute, and SpO2 97%. Patient stated his headache was gone and he felt fine. Lead nurse educated patient on communicating with primary care provider about his reactions to the vaccine and seeking emergency care if symptoms worsen or has difficulty swallowing/breathing. At 1018, patient left facility to self with steady gait and unlabored breathing.
dry skin; fatigue; This is a Spontaneous report from a contactable consumer. A 51-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 24Mar2021 as 1st dose, single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. It was reported that during follow up of Ibrance, patient reported skipping 7 doses due to receiving Covid-19 vaccine, recommended by physician On unknown date in Apr2021 the patient experienced dry skin, fatigue. Patient was doing ok on medication, just dry skin. Dry skin was controlled with OTC creams. It was reported that medication will be set for delivery for Apr2021. The outcome of the event fatigue was unknown and dry skin was recovered on an unspecified date in 2021.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
The patient was nervous for first dose of pfizer covid 19 vaccine. she got the dose and sat down. A few minutes later stated was not feeling well. She took a drink of water. She was positioned with head between legs in case she would faint. Patient then fainted a few minutes after that by falling forward and hit her head on sanitizing station. Emt were called and she was not taken to the hospital. her boyfriend came to pick her up.
BRIEF OVERVIEW: Admission Date: 8/8/2023 Discharge Date: Aug 10, 2023 Discharge Disposition:  home or self care   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 [U07.1] Weakness [R53.1]   HOSPITAL COURSE: 92-year-old male with a past medical history significant for hypertension diabetes as well as CKD stage IIIA who presents due to complaints of generalized weakness with cough and fatigue.  Patient was found to have COVID-19 but was otherwise hemodynamically stable with an acute on chronic kidney injury noted on admission.  Patient was given dexamethasone despite being on room air and was thought to warrant admission to the hospital.   By 8/9, renal function had improved and patient remained on room air and was feeling somewhat better.  Dexamethasone was discontinued and remdesivir was started.   After observing the patient on 08/09 overnight, by 8/10, he is feeling well enough to go home.  His blood pressure had improved his baseline and he was thought to be stable for discharge home with resumption of his home oral antihypertensive agents.  Patient discharged home in stable condition.
Only diluent administered; Only diluent administered; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received MMR (Priorix) for prophylaxis.   Co-suspect products included mmr vaccine pre-filled syringe device (Priorix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Priorix and Priorix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Priorix and Priorix Pre-Filled Syringe Device, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 15-FEB-2023 Reporter's comment: The medical assistant reported that only the diluent was given to a patient. No other information available will call back later.  The reporter consent to follow up. Additional Supportive Information: The patients received Priorix vaccines but only the diluent, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Pt. was extremely fussy with persistant crying for nearly 72 hours and left leg was red and indurated but resolved 4 days after the vaccination administration. The fussiness was most prominent the day after vaccination.
Received an expired vaccine; Vaccine administered from a vial that was 1st punctured on 7May2021 at 4:38PM and left out at room temperature; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received an expired vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered from a vial that was 1st punctured on 7May2021 at 4:38PM and left out at room temperature) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     The medical history was not provided by the reporter.  Concomitant products included ETANERCEPT (ENBREL), METHOTREXATE, FAMOTIDINE and FOLIC ACID for an unknown indication.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received an expired vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered from a vial that was 1st punctured on 7May2021 at 4:38PM and left out at room temperature). On 08-May-2021, EXPIRED PRODUCT ADMINISTERED (Received an expired vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered from a vial that was 1st punctured on 7May2021 at 4:38PM and left out at room temperature) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: New event temperature excursion of vaccine updated. On 11-May-2021: Follow-up contains NNI
My wife and I believe that the vaccine (ZOSTAVAX) can give a person genital herpes! We received our injections on 03-05-07 and we both developed herpes within a few months.
Fever 101, chills, elevated resting heart rate 118 whereas normally 60, reduced PO2 to 92, recovered to normal post 3 days
BULLOUS DISEASE; LOCAL SWELLING; LOCAL ERYTHEMA; PRURITUS; ZOSTER; PITYRIASIS ROSEA; ALOPECIA; OTHER CONDITIONS; MORBILLIFORM; URTICARIA; This spontaneous report was received from literature. This report concerned multiple patients (11 individuals) of age between 28-60 of an unspecified sex, race and ethnicity. The objective of the study is to describe the distribution of COVID-19 vaccine skin reactions was unclear and suggested we delineate each reaction pattern as local, distant, or generalized approach, study also captured an extensive vaccine reactogenicity profile or to highlight new data on skin reactions to other COVID-19 vaccines, Johnson & Johnson's Ad26.COV2.S. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, among 10 individuals (females), 15 vaccine reactions were experienced among patients which included,1 had bullous disease, 1 had local swelling, 1 had local erythema, 2 had pruritus, 2 had urticaria, 1 had morbilliform, 1 had zoster, 1 had pityriasis rosea, 2 had alopecia and 3 had other conditions (Adverse drug reaction NOS). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the local swelling, local erythema, pruritus, urticaria, morbilliform, zoster, pityriasis rosea, bullous disease, alopecia and other conditions was not reported. The authors emphasized that Analysis of the underlying mechanisms for each pattern of skin reaction and systematic characterization of these cutaneous manifestations are paramount to understanding how these side effects influence vaccine adoption, particularly as additional doses, boosters, and vaccine mixing become increasingly common. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220360358-COVID-19 VACCINE AD26.COV2.S-Bullous disease. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Febrile Seizures started at 11:00 am one big one followed 20 minutes later by an ongoing seizure that wouldn't stop. ATIVAN was administered in the ER and then a sedative and a breathing tube. We were sent to the PICU for 2 days of video EKG, spinal tap and blood work. Everything came back negative and it was ruled FEBRILE SEIZURE brought on by vaccination.
Pt. seen for WCV 04/22/13 AM. Mother called 04/23/13 AM - states pt. has red, swollen area Lt. thigh. Pt. seen by provider 04/23/13 PM. Reddened area 'egg sized" with indurated area quarter sized. Was recommended Tx with BENADRYL or ZYRTEC; ice locally.